科美診斷(688468.SH):擬推2021年限制性股票激勵計劃
格隆匯12月27日丨科美診斷(688468.SH)公佈2021年限制性股票激勵計劃(草案),該激勵計劃擬向激勵對象授予600萬股限制性股票,約佔該激勵計劃草案公吿時公司股本總額40,100.00萬股的1.50%。
其中首次授予540萬股,約佔該激勵計劃草案公吿時公司股本總額的1.35%,首次授予部分佔本次授予權益總額的90.00%;預留60萬股,約佔該激勵計劃草案公吿時公司股本總額的0.15%,預留部分佔本次授予權益總額的10.00%。
該計劃限制性股票的首次授予價格不低於7.15元/股。
該激勵計劃首次授予的激勵對象總人數為37人,約佔公司全部職工人數619人(截至2020年12月31日)的5.98%。包括公司公吿該計劃時在公司(含子公司)任職的高級管理人員及業務骨幹。
該激勵計劃有效期自限制性股票首次授予之日起至激勵對象獲授的限制性股票全部歸屬或作廢失效之日止,最長不超過75個月。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.